In MedTech Dive, Greg Levine Discusses Chevron Doctrine Reversal Implications for Medical Device Industry
July 13, 2024
July 13, 2024
BOSTON, Massachusetts, July 13 -- Ropes and Gray, a law firm, issued the following news:
In a MedTech Dive article, life sciences regulatory & compliance partner Greg Levine discussed how the recent U.S. Supreme Court decision to overturn the Chevron doctrine could impact the medical device industry and lead to more challenges of Food and Drug Administration regulations, including the agency's rule on laboratory developed tests.
The Supreme Court ruling made cl . . .
In a MedTech Dive article, life sciences regulatory & compliance partner Greg Levine discussed how the recent U.S. Supreme Court decision to overturn the Chevron doctrine could impact the medical device industry and lead to more challenges of Food and Drug Administration regulations, including the agency's rule on laboratory developed tests.
The Supreme Court ruling made cl . . .